Iatrogenic third degree atrioventricular block due to alpha interferon is r
are.
The authors present a case which occured with low dosage, regressed when tr
eatment was withdrawn and reappeared when treatment was reintroduced. The p
hysiopathological mechanism of disease of the conduction pathways and its g
eneral cardiotoxicity is not yet understood.
The secondary effects of this increasingly widely used anti-tumoral and ant
i-infectious drug should be recognised in order to prevent them. Initial ca
rdiological investigation and follow-up are indicated to ensure this preven
tion.